此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Epilepsy Enhanced Care

2026年7月12日 更新者:Payam Tabaee Damavandi、Ente Ospedaliero Cantonale, Bellinzona

Evaluating the Impact of Epilepsy Enhanced Care on Health Literacy in People With Epilepsy: A Nurse-led Educational Intervention Study

Background: Epilepsy is a common brain condition that causes repeated seizures. People with epilepsy often need a lot of information to manage their health, but many do not receive enough education about their condition. Having good health literacy (the ability to find, understand, and use health information) is important for managing epilepsy well.

Objective: This study aims to test whether a special educational program led by a trained epilepsy nurse, called "Epilepsy Enhanced Care," helps adults with epilepsy better understand and manage their health.

Study design: This is a prospective, non-randomized, controlled study involving adults (aged 18 years or older) with epilepsy. Participants will be divided into three groups:

  • Intervention group: Patients with newly diagnosed epilepsy who will receive the "Epilepsy Enhanced Care" educational program in addition to their usual care.
  • Control group 1: Patients with newly diagnosed epilepsy who will receive only their usual care.
  • Control group 2: Patients who have had epilepsy for at least one year and will receive only their usual care.

Intervention: The "Epilepsy Enhanced Care" program is a structured, one-on-one educational session delivered by a specialized epilepsy nurse within 2 months of diagnosis. The session covers topics such as epilepsy types, medications, safety planning, and lifestyle management. Patients and their caregivers may attend together. After the session, participants can contact the nurse by phone or email with further questions.

Outcomes: The main outcome is the change in health literacy from the start of the study to 3 months after the intervention. Secondary outcomes include changes in epilepsy-specific knowledge, self-management skills, quality of life, anxiety, depression symptoms, and how often patients use healthcare services.

Study duration: Participants in the intervention group and control group 1 will be followed for 12 months. Participants in control group 2 will be assessed at a single time point. The entire study is expected to take 24 months.

Risks and benefits: The intervention involves only education and counseling, with no medications or medical devices. The risks are minimal, and participation is voluntary.

研究概览

地位

尚未招聘

条件

研究类型

介入性

注册 (估计的)

166

阶段

  • 不适用

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Age ≥18 years;
  • Confirmed epilepsy diagnosis (ILAE criteria);
  • Ability to provide informed consent (or legal representative);
  • Sufficient Italian proficiency.

Exclusion Criteria:

  • Previous participation in a structured epilepsy education program;
  • Severe untreated comorbidities precluding attendance.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Index group (newly diagnosed epilepsy + intervention)
Epilepsy Enhanced Care
A structured, nurse-led educational program delivered by a specialized epilepsy nurse. Includes a comprehensive consultation (within 2 months after diagnosis) covering epilepsy types, anti-seizure medications, safety planning, lifestyle management. Caregivers encouraged to attend. Follow-up access via telephone/email.
无干预:Control group 1 (newly diagnosed epilepsy, standard care only)
无干预:Control group 2 (established epilepsy, standard care only, cross-sectional)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Improvement in health literacy
大体时间:From baseline to 3 months after enrollment
Measured using Domain 2 ("Having sufficient information to manage my health") of the Health Literacy Questionnaire (HLQ).
From baseline to 3 months after enrollment

次要结果测量

结果测量
措施说明
大体时间
Changes in scores on other seven domains of the HLQ
大体时间:From baseline to 3 and 12 months after enrollment
For each endpoint, the change in score from baseline to follow-up will be measured in the intervention groups, and scores will be compared between the intervention and control groups at follow-up
From baseline to 3 and 12 months after enrollment
Change in Epilepsy-specific knowledge score
大体时间:From baseline to 3 and 12 months after enrollment
From baseline to 3 and 12 months after enrollment
Change in Epilepsy Self-Management score
大体时间:From baseline to 3 and 12 months after enrollment
From baseline to 3 and 12 months after enrollment
Change in Generalized Anxiety Disorder 7 score
大体时间:From baseline to 3 and 12 months after enrollment
From baseline to 3 and 12 months after enrollment
Change in Neurological Disorders Depression Inventory for Epilepsy score
大体时间:From baseline to 3 and 12 months after enrollment
From baseline to 3 and 12 months after enrollment
Healthcare utilization
大体时间:From baseline to 3 and 12 months after enrollment
Frequency of epilepsy-related emergency department visits, epilepsy-related hospitalizations, and unscheduled neurology consultations, collected through patient self-report and, where available, verified through electronic medical records.
From baseline to 3 and 12 months after enrollment

其他结果措施

结果测量
大体时间
Patient satisfaction score
大体时间:At 3 months after enrollment
At 3 months after enrollment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2028年8月1日

研究完成 (估计的)

2028年8月1日

研究注册日期

首次提交

2026年7月12日

首先提交符合 QC 标准的

2026年7月12日

首次发布 (实际的)

2026年7月16日

研究记录更新

最后更新发布 (实际的)

2026年7月16日

上次提交的符合 QC 标准的更新

2026年7月12日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • CE5171

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅